These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3172136)

  • 1. New "ofloxacin" type antibacterial agents. Incorporation of the spiro cyclopropyl group at N-1.
    Kiely JS; Schroeder MC; Sesnie JC
    J Med Chem; 1988 Oct; 31(10):2004-8. PubMed ID: 3172136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridonecarboxylic acids as antibacterial agents. IX. Synthesis and structure-activity relationship of 3-substituted 10-(1-aminocyclopropyl)-9-fluoro-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]- 1,4-benzoxazine-6-carboxylic acids and their 1-thio and 1-aza analogues.
    Todo Y; Takagi H; Iino F; Fukuoka Y; Takahata M; Okamoto S; Saikawa I; Narita H
    Chem Pharm Bull (Tokyo); 1994 Dec; 42(12):2569-74. PubMed ID: 7697774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antibacterial activities of optically active ofloxacin.
    Hayakawa I; Atarashi S; Yokohama S; Imamura M; Sakano K; Furukawa M
    Antimicrob Agents Chemother; 1986 Jan; 29(1):163-4. PubMed ID: 3460520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chiral DNA gyrase inhibitors. 2. Asymmetric synthesis and biological activity of the enantiomers of 9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H- pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid (ofloxacin).
    Mitscher LA; Sharma PN; Chu DT; Shen LL; Pernet AG
    J Med Chem; 1987 Dec; 30(12):2283-6. PubMed ID: 2824776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sub-inhibitory and post-antibiotic effects of an optically active isomer of ofloxacin.
    Tanaka M; Une T; Osada Y
    Arzneimittelforschung; 1989 Jul; 39(7):750-4. PubMed ID: 2506868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis and Molecular Docking of 1-Cyclopropyl-6- Fluoro-4-Oxo-7-{4-[2-(4-Substituted-Phenyl)-2-(Substituted)-Ethyl] -1-Piperazinyl}-1,4-Dihydroquinoline-3-Carboxylic Acid as an Antimicrobial Agents.
    Patel MM; Patel LJ
    Curr Drug Discov Technol; 2017; 14(4):255-269. PubMed ID: 28240185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antibacterial activity of FA103, a new quinolone derivative of C-7 position with 7-perhydrodiazepinone.
    Imamori K; Asaoka T; Matsumoto M; Maebashi K; Matsuda H; Tahara Y
    Jpn J Antibiot; 1995 Dec; 48(12):1891-8. PubMed ID: 8587163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the new quinolone antibacterial agent levofloxacin with fenbufen in mice.
    Furuhama K; Akahane K; Tawara K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):406-8. PubMed ID: 1622442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinolone antibacterial agents. Synthesis and structure-activity relationships of 8-substituted quinoline-3-carboxylic acids and 1,8-naphthyridine-3-carboxylic acids.
    Sanchez JP; Domagala JM; Hagen SE; Heifetz CL; Hutt MP; Nichols JB; Trehan AK
    J Med Chem; 1988 May; 31(5):983-91. PubMed ID: 3361584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Alkoxyimidazoquinolones as potential antibacterial agents. Synthesis and structure-activity relationships.
    Fujita M; Egawa H; Miyamoto T; Nakano J; Matsumoto J
    Chem Pharm Bull (Tokyo); 1996 May; 44(5):987-90. PubMed ID: 8689728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new fluoroquinolone derivative exhibits inhibitory activity against human immunodeficiency virus type 1 replication.
    Kashiwase H; Momota K; Ohmine T; Komai T; Kimura T; Katsube T; Nishigaki T; Kimura S; Shimada K; Furukawa H
    Chemotherapy; 1999; 45(1):48-55. PubMed ID: 9876209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ethylenediaminetetraacetic acid and gentamicin on the antibacterial activity of pyridone carboxylic acid derivatives against gram-negative bacilli.
    Miyake Y; Mitsui K; Suginaka H
    J Antimicrob Chemother; 1986 Mar; 17(3):327-32. PubMed ID: 3084441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antibacterial activities of substituted 7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxyl ic acids.
    Hayakawa I; Hiramitsu T; Tanaka Y
    Chem Pharm Bull (Tokyo); 1984 Dec; 32(12):4907-13. PubMed ID: 6534539
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolation and identification of metabolites of ofloxacin in rats, dogs and monkeys.
    Sudo K; Okazaki O; Tsumura M; Tachizawa H
    Xenobiotica; 1986 Aug; 16(8):725-32. PubMed ID: 3464137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological testing of non-fluorinated analogues of levofloxacin.
    Gray JL; Almstead JI; Gallagher CP; Hu XE; Kim NK; Taylor CJ; Twinem TL; Wallace CD; Ledoussal B
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2373-5. PubMed ID: 12824037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New quinolone antibacterial agents. Synthesis and biological activity of 7-(3,3- or 3,4-disubstituted-1-pyrrolidinyl)quinoline-3-carboxylic acids.
    Hagen SE; Domagala JM; Heifetz CL; Sanchez JP; Solomon M
    J Med Chem; 1990 Feb; 33(2):849-54. PubMed ID: 2153830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimycoplasmal activities of (S)-(-)-9-fluoro-2,3-dihydro-3-methyl-10 -[4-(2-pyridyl)-1-piperazinyl]-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine -6-carboxylic acid (YH-6) in comparison with other antibiotics in vitro.
    Ye H; Wu JM; Yang YS; Ji RY; Chen KX
    Zhongguo Yao Li Xue Bao; 1999 Nov; 20(11):1031-4. PubMed ID: 11270970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antibacterial activity of nitroaryl thiadiazole-levofloxacin hybrids.
    Foroumadi A; Mansouri S; Emami S; Mirzaei J; Sorkhi M; Saeid-Adeli N; Shafiee A
    Arch Pharm (Weinheim); 2006 Nov; 339(11):621-4. PubMed ID: 17036368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinolone antibacterials: preparation and activity of bridged bicyclic analogues of the C7-piperazine.
    Kiely JS; Hutt MP; Culbertson TP; Bucsh RA; Worth DF; Lesheski LE; Gogliotti RD; Sesnie JC; Solomon M; Mich TF
    J Med Chem; 1991 Feb; 34(2):656-63. PubMed ID: 1995890
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.